Publications by authors named "Daryl Hoban"

Claim this Profile
C
Clinical And Bacteriological Impact Of Clarithromycin In Streptococcal Pharyngitis: Findings From A Meta-Analysis Of Clinical Trials.
Daryl J Hoban, Jos Nauta

Drug Des Devel Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of ceftolozane-tazobactam and comparators against Pseudomonas aeruginosa from patients in different risk strata - SMART United States 2016-2017.
Sibylle H Lob, Daryl J Hoban, Katherine Young, Mary R Motyl, Daniel F Sahm

J Glob Antimicrob Resist· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study.
George G Zhanel, Heather J Adam, Melanie R Baxter, Jeff Fuller, Kimberly A Nichol, Daryl J Hoban

J Antimicrob Chemother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
Melissa G McCracken, Heather J Adam, Joseph M Blondeau, Andrew J Walkty, James A Karlowsky, Daryl J Hoban

J Antimicrob Chemother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16.
Alyssa R Golden, Melanie R Baxter, Ross J Davidson, Irene Martin, Walter Demczuk, Daryl J Hoban

J Antimicrob Chemother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of MRSA in Canada from 2007 to 2016.
Kimberly A Nichol, Heather J Adam, George R Golding, Philippe R S Lagacé-Wiens, James A Karlowsky, Daryl J Hoban

J Antimicrob Chemother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
Andrew J Denisuik, James A Karlowsky, Heather J Adam, Melanie R Baxter, Philippe R S Lagacé-Wiens, Daryl J Hoban

J Antimicrob Chemother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16.
Philippe R S Lagacé-Wiens, Heather J Adam, Susan Poutanen, Melanie R Baxter, Andrew J Denisuik, Daryl J Hoban

J Antimicrob Chemother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study.
Andrew J Denisuik, Lauren A Garbutt, Alyssa R Golden, Heather J Adam, Melanie Baxter, Daryl J Hoban

J Antimicrob Chemother· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of imipenem/relebactam against Gram-negative bacilli from global ICU and non-ICU wards: SMART 2015-2016.
Sibylle H Lob, Daryl J Hoban, Katherine Young, Mary R Motyl, Daniel F Sahm

J Glob Antimicrob Resist· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016.
Sibylle H Lob, Meredith A Hackel, Daryl J Hoban, Katherine Young, Mary R Motyl

Eur J Clin Microbiol Infect Dis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
James A Karlowsky, Heather J Adam, Alyssa R Golden, Melanie R Baxter, Kim A Nichol, Daryl J Hoban

J Antimicrob Chemother· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
Heather J Adam, Alyssa R Golden, James A Karlowsky, Melanie R Baxter, Kim A Nichol, Daryl J Hoban

J Antimicrob Chemother· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
Alyssa R Golden, Heather J Adam, James A Karlowsky, Melanie Baxter, Kimberly A Nichol, Daryl J Hoban

J Antimicrob Chemother· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
George G Zhanel, Courtney K Lawrence, Heather Adam, Frank Schweizer, Sheryl Zelenitsky, Daryl J Hoban

Drugs· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of ceftolozane/tazobactam versus antimicrobial non-susceptible Pseudomonas aeruginosa clinical isolates including MDR and XDR isolates obtained from across Canada as part of the CANWARD study, 2008-16.
Andrew Walkty, Heather Adam, Melanie Baxter, Philippe Lagacé-Wiens, James A Karlowsky, Daryl J Hoban

J Antimicrob Chemother· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
George G Zhanel, Courtney K Lawrence, Heather Adam, Frank Schweizer, Sheryl Zelenitsky, Daryl J Hoban

Drugs· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013-2015.
James A Karlowsky, Daryl J Hoban, Meredith A Hackel, Sibylle H Lob, Daniel F Sahm

Braz J Infect Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invitro activity of imipenem-relebactam against gram-negative bacilli isolated from patients with lower respiratory tract infections in the United States in 2015 - Results from the SMART global surveillance program.
Sibylle H Lob, Meredith A Hackel, Krystyna M Kazmierczak, Daryl J Hoban, Katherine Young

Diagn Microbiol Infect Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
James A Karlowsky, Daryl J Hoban, Meredith A Hackel, Sibylle H Lob, Daniel F Sahm

J Med Microbiol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
George G Zhanel, Erika Hartel, Heather Adam, Sheryl Zelenitsky, Michael A Zhanel, Daryl J Hoban

Drugs· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014.
Meredith Hackel, Krystyna M Kazmierczak, Daryl J Hoban, Douglas J Biedenbach, Samuel K Bouchillon

Antimicrob Agents Chemother· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014.
Sibylle H Lob, Lindsay E Nicolle, Daryl J Hoban, Krystyna M Kazmierczak, Robert E Badal

Diagn Microbiol Infect Dis· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.
George G Zhanel, Doris Cheung, Heather Adam, Sheryl Zelenitsky, Alyssa Golden, Daryl J Hoban

Drugs· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii.
Sibylle H Lob, Daryl J Hoban, Daniel F Sahm, Robert E Badal

Int J Antimicrob Agents· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis